Early research (Phase 1)Ended earlyNCT00450879
What this trial is testing
Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery
Who this might be right for
Male Breast CarcinomaRecurrent Breast CarcinomaStage IA Breast Cancer+4 more
National Cancer Institute (NCI) 19